Baird downgraded ABM Industries to Neutral from Outperform with a price target of $51, down from $52, following the fiscal Q1 results. The company’s’ core demand is softening as COVID-related disinfection revenues are now effectively zero, and customer descoping and fewer work orders are pressuring revenue where volumes are flat-to-negative, the analyst tells investors in a research note. The firm says its thesis of easing labor cost pressure isn’t materializing. It no longer shares catalysts for ABM share outperformance.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABM: